Vault-13

XILIO THERAPEUTICS INC

COM · CUSIP 98422T100

1 institutional holders +0 vs Q1 2026
650,389650.4k shares reported held*
$6.2mreported value*
0 new 0 added 0 reduced 0 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $9.58.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

02040Q3 22: 30Q4 22: 29Q1 23: 33Q2 23: 33Q3 23: 32Q4 23: 35Q1 24: 32Q2 24: 33Q3 24: 34Q4 24: 36Q1 25: 36Q2 25: 36Q3 25: 36Q4 25: 37Q1 26: 1Q2 26: 11Q3 22Q3 23Q3 24Q3 25Q2 26
Numbers
QuarterHolders
Q3 202230
Q4 202229
Q1 202333
Q2 202333
Q3 202332
Q4 202335
Q1 202432
Q2 202433
Q3 202434
Q4 202436
Q1 202536
Q2 202536
Q3 202536
Q4 202537
Q1 20261
Q2 20261

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q3 24: 13 bought or addedQ3 24: 8 cut or sold outQ4 24: 10 bought or addedQ4 24: 11 cut or sold outQ4 24Q1 25: 14 bought or addedQ1 25: 13 cut or sold outQ2 25: 9 bought or addedQ2 25: 16 cut or sold outQ2 25Q3 25: 10 bought or addedQ3 25: 7 cut or sold outQ4 25: 15 bought or addedQ4 25: 14 cut or sold outQ4 25Q1 26: 0 bought or addedQ1 26: 36 cut or sold outQ2 26: 0 bought or addedQ2 26: 0 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 2024138
Q4 20241011
Q1 20251413
Q2 2025916
Q3 2025107
Q4 20251514
Q1 2026036
Q2 202600

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
GILEAD SCIENCES, INC. 13G · passive investor no change · filed 2026-02-12 19.9% no change 14.5m 2026-02-12
Coastlands Capital LP 13G · institution new · filed 2025-12-11 10.0% new 5.3m 2025-12-11
Sirenia Capital Management LP 13G · institution new · filed 2026-05-15 9.9% new 1.1m 2026-05-15
AbbVie Inc. 13G · passive investor new · filed 2025-02-18 9.0% new 4.3m 2025-02-18
Bain Capital Life Sciences Fund II, L.P. 13G · passive investor filed 2026-02-17 8.5% 6.3m 2026-02-17
STEMPOINT CAPITAL LP 13G · institution +1.2 pts · filed 2026-02-17 8.4% +1.2 pts 6.0m 2026-02-17
Frazier Life Sciences Public Fund, L.P. 13G · passive investor -3.2 pts · filed 2026-02-13 6.7% -3.2 pts 4.7m 2026-02-13

Fell to 5% or below in the last year: Point72 Asset Management, L.P. (0.0%, 2026-05-15)

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 GILEAD SCIENCES, INC. 0.38% of their portfolio FOSTER CITY, CA 650,389650.4k $6.2m $6.2m 0.38% Unchanged